Bridgebio Pharma Inc (BBIO)

R&D to Revenue

61.33%

Quarterly · Period ending:

BBIO logo

BBIO R&D to Revenue

Latest reported61.33%
BBIO Quarterly R&D/Revenue (0.00% → 61.33%)
High-resolution chart · PNG

BBIO r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Bridgebio Pharma Inc R&D to Revenue — Quarterly
Period endingR&D to Revenue
61.3306%
65.1035%
92.1001%
93.5162%
100.6024%
95.5399%
2,216.083%
4,408.6384%
5,290.3598%
66.7734%
7,462.808%
3,058.812%
6,550.1523%
5,085.4874%
4,861.0695%
27,370.1183%
146.991%
6,354.7226%
948.316%
4,449.872%
188.7309%
26,527.9221%
73,913.1148%
1,132.6443%
0%
0%
415.9852%
206.7163%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.